ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

BACKGROUND: Neoadjuvant therapy is increasingly the standard of care in the management of locally advanced adenocarcinoma of the oesophagus and junction (AEG). In randomised controlled trials (RCTs), the MAGIC regimen of pre- and postoperative chemotherapy, and the CROSS regimen of preoperative chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, JV, Preston, SR, O’Neill, B, Baeksgaard, L, Griffin, SM, Mariette, C, Cuffe, S, Cunningham, M, Crosby, T, Parker, I, Hofland, K, Hanna, G, Svendsen, LB, Donohoe, CL, Muldoon, C, O’Toole, D, Johnson, C, Ravi, N, Jones, G, Corkhill, AK, Illsley, M, Mellor, J, Lee, K, Dib, M, Marchesin, V, Cunnane, M, Scott, K, Lawner, P, Warren, S, O’Reilly, S, O’Dowd, G, Leonard, G, Hennessy, B, Dermott, R Mc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457631/
https://www.ncbi.nlm.nih.gov/pubmed/28578652
http://dx.doi.org/10.1186/s12885-017-3386-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457631/
https://www.ncbi.nlm.nih.gov/pubmed/28578652
http://dx.doi.org/10.1186/s12885-017-3386-2

Ejemplares similares